CuspAI just raised a $450M Series B at a $2.6B valuation — 5x its worth nine months ago — to use AI to invent the materials the physical world is missing. Kleiner Perkins and NEA led; Bezos Expeditions backed.
Merck's Lipfendra (enlicitide) is the first oral PCSK9 inhibitor — a once-daily pill that cuts LDL up to 59%, matching the injectables at $315 a month.
TSMC's Q2 2026 net profit soared 77.4% to a record NT$706.56 billion on $40.2 billion in revenue — the clearest proof yet that the AI boom is real, paid-for, and printing cash.
Databricks just repriced 40% higher to $188 billion in seven months — a ~$3B round led by Coatue, still stubbornly private, and quietly running the AI economy's plumbing.
Walden Robotics left stealth with a $300M seed at a $1.1B valuation — and its wheeled robots are already working in a Toyota factory.
Socure raised $156M at a $5.2B valuation and bought agentic-AI startup Fravity to fight machine-speed fraud with AI agents of its own.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA cleared Revolution Medicines' daraxonrasib, the first broad RAS-targeted pill for metastatic pancreatic cancer, doubling median survival to 13.2 months at a $477,000-a-year list price.
The FDA cleared GENGLYCOS, Ultragenyx's first gene therapy: a one-time $2.7 million infusion targeting the root cause of glycogen storage disease type Ia.
AusperBio raised $120M to push AHB-137, an antisense drug that cleared hepatitis B in 68% of a small trial, toward the first functional cure for a disease 240 million people live with.
